Telephone
61.7.3860.3700
Address
Unit 1 50 Parker Court Pinkenba, Queensland (QLD) 4008
Description
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.06 - 0.24
Trade Value (12mth)
AU$112,660.00
1 week
3.7%
1 month
21.74%
YTD
86.67%
1 year
52.17%
All time high
1.73662
EPS 3 yr Growth
-68.200%
EBITDA Margin
-179.60%
Operating Cashflow
-$18m
Free Cash Flow Return
-31.90%
ROIC
-36.30%
Interest Coverage
-599.40
Quick Ratio
8.70
Shares on Issue (Fully Dilluted)
1822m
HALO Sector
Healthcare
Next Company Report Date
29-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.27
Date | Announcements |
---|---|
31 October 23 |
Appendix 4C & Quarterly Activities Report - Sep-23 Qtr
×
Appendix 4C & Quarterly Activities Report - Sep-23 Qtr |
31 October 23 |
Notice of Annual General Meeting and Voting Form
×
Notice of Annual General Meeting and Voting Form |
31 October 23 |
Virtual Meeting Online Guide
×
Virtual Meeting Online Guide |
31 October 22 |
Change of Director's Interest Notice - Mrs Janet West AM
×
Change of Director's Interest Notice - Mrs Janet West AM |
31 October 22 |
Change of Director's Interest Notice - Mr Donald Williams
×
Change of Director's Interest Notice - Mr Donald Williams |
31 October 22 |
Change of Director's Interest Notice - Mr David Anderson
×
Change of Director's Interest Notice - Mr David Anderson |
31 October 22 |
Change of Director's Interest Notice - Correction
×
Change of Director's Interest Notice - Correction |
31 October 08 |
AGM Presentation - Confirms Growth Prospects
×
AGM Presentation - Confirms Growth Prospects |
31 July 23 |
Notice received under section 203D of the Corporations Act
×
Notice received under section 203D of the Corporations Act |
31 July 23 |
Five Additional Medical Policies Achieved
×
Five Additional Medical Policies Achieved |
31 January 22 |
Appendix 4C & Quarterly Activities Report
×
Appendix 4C & Quarterly Activities Report |
31 August 23 |
Appendix 4E
×
Appendix 4E |
31 August 23 |
2023 Annual Report
×
2023 Annual Report |
31 August 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
30 October 14 |
AGM Presentation
×
AGM Presentation |
30 November 23 |
2023 AGM - Chair's Address and Presentation
×
2023 AGM - Chair's Address and Presentation |
30 November 23 |
IPD AGM - Results of Meeting
×
IPD AGM - Results of Meeting |
30 May 23 |
Share Purchase Plan Opens
×
Share Purchase Plan Opens |
30 March 23 |
Change of Director's Interest Notice - Mr Richard Valencia
×
Change of Director's Interest Notice - Mr Richard Valencia |
30 March 09 |
Presentation for Australian and US Investment Roadshow
×
Presentation for Australian and US Investment Roadshow |
30 June 23 |
Revised Security Trading Policy
×
Revised Security Trading Policy |
30 January 23 |
New Version of NCCN Guidelines for Breast Cancer
×
New Version of NCCN Guidelines for Breast Cancer |
30 January 23 |
Appendix 4C & Quarterly Activities Report - Dec-22 Qtr
×
Appendix 4C & Quarterly Activities Report - Dec-22 Qtr |
30 August 23 |
Response to Notice 249D from IPDs Executive Leadership Team
×
Response to Notice 249D from IPDs Executive Leadership Team |
30 August 22 |
Director Appointment & Retirement
×
Director Appointment & Retirement |
30 August 22 |
Initial Director's Interest Notice - Mrs Janet West
×
Initial Director's Interest Notice - Mrs Janet West |
30 August 18 |
Annual Report 30 June 2018
×
Annual Report 30 June 2018 |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.